Go back

Google’s AI boss made OpenAI issue code red. Now he wants to solve disease. | Titans and Disruptors

29m 17s

Google’s AI boss made OpenAI issue code red. Now he wants to solve disease. | Titans and Disruptors

In this interview, Demis Hassabis reflects on his journey from chess prodigy and astronomy enthusiast to leading Google’s AI revolution. He sold DeepMind to Google in 2014, foreseeing its pivotal role despite higher offers from Meta. This acquisition spurred the creation of OpenAI. Hassabis highlights DeepMind’s key breakthroughs: AlphaGo’s 2016 victory, which launched the modern AI race, and AlphaFold, which solved a 50-year-old biology challenge by predicting protein structures. This work earned him a Nobel Prize and powers Isomorphic Labs, a startup aiming to “solve all disease” by using AI to accelerate drug discovery—reducing a decade-long, billion-dollar process to in silico design. At Google, Hassabis merged DeepMind and Google Brain to create Gemini, fostering a fast-shipping culture reminiscent of Google’s golden era. He manages this dual role by leading interdisciplinary teams and working late nights for creative thinking. With founders like Sergey Brin now involved, Hassabis remains focused on ambitious goals: achieving artificial general intelligence and transforming human health through AI-driven science.

Transcription

5942 Words, 32556 Characters

English
In 10, 15 years time will be in a kind of new golden era of discovery. That's why hope are kind of new Renaissance. We're in the thick of the AI revolution, but we might look back on January 2014 as one of the most pivotal moments in business history. That was the month, but Demis Ashabis sold his AI company DeepMind to Google. He rebuffed a higher offer from Metas Mark Zuckerberg and the acquisition scared Elon Musk so much that he decided to launch a rival company with Sam Altman, now called OpenAI. Fast forward to today, and Demis is still the one to beat. He runs all of Google's AI initiatives, including Gemini, which is quickly eating away at OpenAI's user base. In his spare time, Demis won a Nobel Prize and he runs a startup called Isomorphic that wants to solve all disease with AI. I sat down with Demis at the World Economic Forum in Davos to learn where he thinks the future is heading. I'm Allison Chanchal and this is Fortune 500 Titans and Disruptors of Industry. We'll be back with Demis after a quick message from our sponsor. Fortune spoke with Deloitte, US CEO Jason Gersardis on maximizing AI agents. And what CEO should consider as they assess and prioritize use cases for AI. This is on the topic of every CXO conversation I'm a part of. And I think the thought process has to be looking for high impact areas that may not be necessarily the most glamorous or high profile functional areas, but are ripe for automation and use of this technology to create efficiencies as well as innovation. And over time, AI agents will be also in customer facing and growth oriented domains. In our case, Deloitte, we're using it within our finance organization, looking at very mundane processes like expense management and working capital management. We're seeing other organizations use it in call centers and with software development that can be automated. What are the key elements for successfully implementing AI agents? Comes down to intentionality. And so I think that intentionality in going functional area by functional area in concert with business and IT leadership on enterprise. It needs to be a mainstream business planning effort that's budgeted. That's KPIs are developed and there's real accountability for actual business outcomes and impact because of agente capabilities. Demis, we're here at Davas. Thank you for making the time to do this. It's great to be here. You've had a huge 2025. It sounds like you're hearing up for great 2026. But before we get into both of those things, I want to just take a step back so people can get to know you a little bit better. One of the things you love is chess. Yes. Your chess master. Yes. You also love astronomy. Yes. And I'm curious how both of those things took you into AI or shape how you think about AI. Yeah. Well, I've always been interested in things like astronomy, cosmology, physics as a kid, because I've always been interested in the big questions. So, you know, what's actually happening here in the universe? Consciousness, nature, consciousness, all of these types of things. So you get sort of drawn to physics if you went into the big questions. And then for me, for chess, I also love games, love strategy, I ended up training my own mind by playing chess as a kid very seriously. And then that got me thinking about thinking and how does the brain work. And then I've combined all that together. That's sort of led me to AI and computers and AI being a way to understand our own minds, but also a perfect tool for science and understand the universe out there. Equipped with a degree in computer science and a PhD in cognitive neuroscience, his service co-founded DeepMind in 2010. The company launched with an ambitious goal to solve intelligence. Under his SOS leadership, the DeepMind team made significant strides in its artificial intelligence models. And just four years later, Google purchased the research startup for hundreds of millions of dollars. You first started DeepMind. You co-founded it a number of years ago. And about 2014, you sold it to Google for about $500 million at the time. It was a hot deal. I know Meta wanted it too. And from my perspective, I think we're going to look back on that moment as one of the most transformative moments in business history. You've given Google the foundation of which to build an incredible AI machine and really take it into the future. When you look back on that, how do you feel about that moment? How did you make that decision? Did you know it was going to be such a big moment at the time? We did actually. Those of us, you know, were involved in the science. So it's interesting. We started DeepMind in 2010, which was, you know, 15 years plus ago now and nobody was talking about AI. But we knew and we set out with the mission of solving intelligence and then using it to solve everything else. So we wanted to be the first company to build artificial general intelligence. And the main thing we wanted to apply to was was solving scientific problems. So when Google came along in 2014 and it was actually driven by Larry at the time, Larry Page, who was the CEO, we knew that in some ways we were sort of underselling. But on the other hand, what mattered to me was not the money. It was being able to, it was the mission and be able to accelerate our progress towards artificial general intelligence and answering these scientific questions that we were trying to solve. And I felt that teaming up with Google would accelerate that mostly because they had obviously enormous compute power. And we see today that how important that is for developing intelligence. So at the time, I did mention to Larry and also the head of search at the time who was driving the deal that this would turn out to be, or they didn't look like it now, it might turn out to be the most important acquisition Google has ever done, which is saying something because they're quite YouTube and they're history and Android. They've got a good history of buying important things. And now if you go back and you look at the origins of open AI in Elon and Sam got together because they were afraid that Google might now have them an monopoly in the AI space with the DeepMind acquisition. So really that also kind of created a mega competitor at the time. Yeah, I guess there's all these sort of butterfly effects that happen. And I think partly also was the success of things like AlphaGo, the first program to beat the world champion at the game of go using these kinds of learning systems that we're familiar with today, you know, reinforcement learning, deep learning at the heart of it. I think that was a big watershed moment as well in 2016 is actually like the 10 year anniversary of that breakthrough this year. And I think that really started the starting gun for the modern AI era, including things like, you know, open AI, I know the founders of that, watch that match and wanted a piece of that action. Following Google's DeepMind acquisition, the company repeatedly made headlines for its accomplishments in AI. In 2015, the company's AI model AlphaGo became the first computer to defeat a champion go player. And later on, it defeated top players in chess, Stratigo and StarCraft 2, which is a popular real-time strategy computer game. In 2020, Google's DeepMind Alpha Fold 2 solved the protein folding problem. For decades, scientists had struggled to predict how protein sequence forms in its final structure. The model accomplished this with remarkable accuracy. The team has since scaled its process to predict over 200 million structures, all of which are now available in an online database. It's obvious to receive the Nobel Prize in Chemistry and a knighthood in 2024 in part for this achievement. Under Google and AlphaBet, you've been able to have a lot of moon shots take risks, try things that haven't necessarily led to money immediately, but have been profound breakthroughs. And one of them, you won a Nobel Prize. So I was wondering, congratulations. Kiss. Incredible. I was wondering if you could just tell me a little bit more about Alpha Fold and why that's such a big deal in terms of how we could be looking at solving diseases moving ahead. Yeah, I think this was one of the benefits of being in this part of Google and AlphaBet was having the resources and the time to really go after these sort of deep scientific problems. And Alpha Fold, I think, is the best example of that. It's basically a solution to a 50-year-old grand challenge in biology of can you determine the three-distructure of a protein just from its amino acid sequence, basically from its genetic sequence. And this is incredibly important because proteins basically do everything in your body from muscles to neurons firing. Everything depends on proteins. And if you know the 3-distructure of a protein, what it looks like in your body, then you kind of partially know what the function it does, what it supports. Obviously it's important also for disease because things can go wrong with proteins. They can fold in the wrong way, like in some of my Alzheimer's, and then that can create a disease. So really important for drug discovery as well as fundamental biology. And Alpha Fold was the solution to this problem that was posed 50 years ago by another Nobel Prize winner, actually, Christian Unfinson, that this should be possible and to go directly from a kind of one-dimensional string of amino acid sequence to this 3-distructure, this kind of how does it scrunch up into a ball. And Alpha Fold was the solution and so efficient, not only is it accurate, we folded all 200 million proteins known to science. And then we put that on a huge database with the European Bioinformatics Institute and for free into the world for everyone to use. So now over 3 million research around the world make use of Alpha Fold every day. Wow. And it's turned into you're using some of it, I believe, for isomorphic, which is a startup that you have. I want to say on the side. Yes. You're doing two huge jobs at once here. You've raised hundreds of millions of dollars in Google, of course, as a backer for isomorphic. Can you just explain the mission there? And you have some lofty goals, like you say, we're going to solve all disease. Yes. You want to say cure. Yes. You say solve. Yes. And also walk me through how hard it is to get a drug to trial because that's historically been very difficult. So that was always the idea behind Alpha Folds. Obviously there's a lot of fundamental science that can be done if you understand the structures of proteins, including designing new proteins that do new things. So you can sort of use Alpha Fold in reverse to sort of go, okay, I want this particular shape. How do I get it from a genetic sequence? But to do drug discovery, knowing the structure of protein is only one small part of that. whole process and usually it takes like on average 10 years to go from understanding a target for a disease to all the way to a drug that's ready for in the market. So it's an enormous amount of time and cost, you know, billions of dollars a decade or more and most drugs fail along the way as only like a kind of 10% success rate. So it's just incredibly inefficient because biology is so complicated. So what I've always dreamed about doing and was the first thing I wanted to apply AI to was human health, improving human health, what could be more important use of AI and alpha-fold was the proof point of that this could be possible and then isomorphic. We spun that out after alpha-fold was done. So three, four years ago to develop additional alpha-fold level breakthroughs surrounding alpha-fold. So you can think more in the chemistry space. So if you now know the structure of a protein, you need to know where the chemical compound you're designing, the drug basically, where it's going to bind to the protein and what is it going to do. And so you need to build other AI systems that can predict all of that. So that's what we've been doing in isomorphic. It's going incredibly well. We have great partners with Eli Lilly and Novartis, the best farmers in the world on, we have like a 17 drug programs active already and we plan to go to, you know, eventually be hundreds. And I think this is the way to make real step change progress in human health is you basically do your search and your hypothesis searching in silico and that's, you know, hundreds, thousand times more efficient than doing it in a wet lab and you save the wet lab part just for the validation step. Of course, eventually you have to test it in, you know, trials, human trials and all those types of things to make sure everything's safe. But you can do all of your search and design or almost all of it in silico. That's the plan. And so 2020's six, you mentioned is going to be a big year. Yeah. I imagine for both Google and for isomorphic, do you anticipate in early 2026? This could be the moment that you get the first drug to trial and may it be in cancer? Yes. So we're working on actually several spaces, a cancer, cardiovascular, immunology, and then eventually we'd like to branch out to all therapeutic areas. We're building a, you know, a general drug discovery engine platform you can think. And we are already in preclinical trials, very early stage for some cancer drugs. And then, you know, hopefully by the end of the year, if those are successful, we'll start going towards clinical trials. How do you manage yourself and your time and your teams? Because you're achieving really, really difficult things, whether it's the launch of Gemini 3, which was very successful and well received, or it's getting drugs to trial. These are two soundingly very different things. Yeah. Different teams to run. You can't be in two places at once. How are you doing this? How are you running two companies? You know, one of my skills is bringing together amazing world class interdisciplinary teams. I've loved managing those teams. I love imposing those management teams together. And I've got incredible teams, both, you know, Google DeepMind and I'm isomorphic. And if we take I'momorphic, for example, we've blended top biologists and chemists along with top machine learning and engineering. And I think there's a lot of magic happens when you have these kind of interdisciplinary groups. And then if we think about on the Google DeepMind side, there we've tried to blend together the best of the start top worlds, like what we were doing at DeepMind originally. And then at scale, you know, in a kind of multi-national scale, then with all the advantages of having these amazing product surfaces that we can immediately deploy, you know, technologies like Gemini 3, 2, and immediately get great feedback from users and also, you know, help in everyday lives of billions of users. So it's amazingly exciting and motivating, actually. And in terms of the way I manage my time is, you know, I don't sleep very much. But a couple hours. Well, if you know a bit more than that, that would be bad for the brain. So I do try and get six. But I have, I'm usually, you know, sleeping habits. I sort of manage during the day and do try and pack my day in the office with as many meetings as possible back to back, almost no time, no break between. Then I get home, spend a little bit of time with the family, have dinner, and then I sort of start a second day of work about 10pm and go to 4am where I do my thinking and kind of more creative work and research work. And it's worked out, you know, I've done that for about a decade now and it works well. I can't imagine being creative at 4 in the morning, but it works. It's my best time for you. Yeah, I come alive at about 1am. In 2023, Google was facing increasing competition from other rapidly growing search engines from the launch of chat GPT. In the same year, Google pivoted to merge two of its AI teams, Deep Mind and Brain under Hesavis' leadership. And the goal was clear, jumpstart the next generation of AI. You're clearly going to motivating teams to do hard things. I know in 2023, a decision was made at Google to put two different AI teams under you. How did you work out management kinks there and get the team shipping again? Because there was this feeling that Google was a little bit of asleep at the wheel for AI and I'm curious if you think that's true and how you got them to wake up. Yeah, well, we had two world-class groups in in original Deep Mind and Google Brain and actually I think often as a collector, we don't get enough credit for the fact that, you know, I think about 90% of modern AI industries built on technology or discoveries made by one of those two groups from transformers to AlphaGo and Deep Reinforced Learning. So we have, when we still have, I think, the Deep person and broadest research bench. So we have an incredible talent, I think, better than any of us in the world by a long way. But it was getting complicated having two groups, especially given the amount of compute needed in this scaling area. So that was really why we had to put the two groups together so we could pull all of the talents together, working on a single project, you know, in Gemini. But also even someone like Google didn't have enough compute to have two frontier projects under one house. So we needed to combine all of our resources together. You know, I'm very collaborative person. I'm very open-minded about different ways of working and try to, I'm always looking to improve as well. Like one of my watch words I live by is this Japanese word "Kai Zen" that I love, which is sort of striving for continual self-improvement. And that's what I always try and do. I'm always in learning mode. Maybe perhaps that's why I like building learning machines because I like learning and there's always something you can learn no matter how expert you are at what you do. And bringing the two groups together and trying to combine the best of both cultures has been great. And I think we're reaping the rewards of that now. And now Google DeepMind is really, we, the way we think about it is like the engine room of Google. So we're sort of powering. It's like the nuclear power palm that's plugged into the rest of this amazing company in Google. And I think one of the things we did is, one of the things I'm very proud of is getting the shipping culture going. And sort of rediscovering, I guess, the golden era of Google back 10, 15 years ago and taking risk, calculated risk, shipping things fast and being innovative. And I think that's all working out really well now whilst at the same time being thoughtful and scientific about and rigorous about what we put out in the world, whether that's engineering or scientifically. And I think, and I hope, you know, we're getting that balance right. And you mentioned kind of going back to the golden era of Google so much so that the founders, at least Sergei seems like he's back involved. How is it like working with him on AI and being Google? It's been great and Larry is two in different ways. Larry more strategically. So he's been in the in the weeds programming away, you know, on things like Gemini. And it's been fantastic seeing them and getting him to work. Are you like, so again, do you know this code right? No, it's more like he chooses what to work on. But it's great seeing him in the office and pushing things in certain directions and it's easier if the founders are kind of heavily involved. And I still act as well, like as a co-founder of Google DeepMind of, of like as a kind of founder or two, right in terms of like what we've got to do and strategically what we pick to do. And that's something I think I've learned to do well over the last, you know, 10, 15 years is when you have some ambitious goal, like solve all disease or build AGI, what are the intermediate goals that are also very ambitious, but there are kind of waypoints. What are the right ones to pick? And I think we've done that historically pretty pretty well with most of the alpha projects, alpha go, alpha fold and so on. And then now Gemini. And I think that's really critical actually for any very ambitious scientific and engineering project is breaking it down into manageable steps so that you can see you on the right direction. And I think that we're very clearly are I think with the technology that we're building. And there's been an incredible couple of years for us and I think we're getting into our groove, I would say. And I think other people and external world are starting to feel that, you know, including things like Wall Street and the SharePyce. In 2005, any questions about whether Google is facing an innovator's dilemma when it came to AI and search were answered. After the first quarter, it's shares skyrocketed driven in part by advancements that made an AI development, including the launch of Google's viral image generation model, nano banana and Gemini 3. Alpha Beth shares rose about 65% by the end of the year, marking its best performance since 2009 and making it the top performing stock among the magnificent seven. It definitely seems like there was some sort of KPI measurement charge ahead unifying moment because I mean the launch of Gemini 3, much fanfare among other watches that caused open AI to go to a code red, which they claim happens all the time. Like, okay. Sure. And then, you know, you have this huge monster deal with Apple that is monumental, like for the industry. So I'm curious what happened internally behind the scene? How did you set those KPIs for the team? And how are you setting them to keep the momentum in 2026? Well, look, I think for me, it always starts with the research, like having the best models in this case and obviously fundamental research feeding into that. And I always believe you then need to reflect that obviously as quickly as possible in your products and then you've got to get your marketing distribution right. But none of it matters if your models aren't besting class in state of the art. And so that's what we focused on first with the Gemini models, but also our other models, things like nano banana, our image model, which went super well. and that was a big part of the success last year, our video model, video world models. So there's more than just large language models, and we're kind of, you know, state of the art on all of those. And then it was about sorting things out internally, almost rebuilding the infrastructure in some way of Google, so that you could reflect very quickly the power of the latest models into the lighthouse products, including search, YouTube, and Chrome, all these amazing surfaces that we have, as well of course as the Gemini app. It was new for everyone in industry, and I think it takes a little while to kind of re-architect things around that. And very much, you know, again, this idea of, of Google DeepMind being the engine room, providing the engine for the rest of the organization to use. And I think that took a year, 18 months to get right, but I think we're seeing the results of that now. And I think there's still more to go by the way, and we can have you in faster velocity. And I think the other thing is just also instilling this culture of intensity and pace and focus, and really focusing only on the things that matter and kind of cutting out distractions. And then maybe the final thing I would say is, I think there's a lot to say, especially today's very noisy world, to just consistently deliver good decisions, good rational decisions, and over time minimal drama. And then I think it's just amazing how much that compounds over time. And you know, I think we're building a lot of momentum now, and I think hopefully we'll see that even more this year. - Sort of like we mentioned before, the decision to sell DeepMind to Google is a monumental moment, transformational moment in business. If you're successful now, I think that will be, perhaps the biggest transformation in business. How does that weigh on you to make sure that you as a leader are driving this in a direction that's good for society, good for the workforce, good for Google, 'cause it is a little bit of an innovator's dilemma, where this is the search king, huge business model based on ads. If you're successful. - Yeah, I don't know. - Sure, well look, I mean, it is a classic innovator's dilemma. I think we've navigated it pretty well so far, and search is more successful than ever. But also there's this aspect of like, if we don't disrupt ourselves, someone else will. So you're better off sort of being ahead of that, I think, and kind of doing it on your terms. And so I think that's what we found. In terms of responsibility, I feel that, I've felt that weight since not just their Google, but before that, a deep mind and before that, even in my academic career, because if we, myself and Shane, especially our chief scientist, when we start a deep mind, it seemed like a fanciful idea, but we really believed that it would be possible to create artificial general intelligence. And we understood what I think more and more people understanding now is how transformative to the world that would be. But also, of course, amazing for things like science and human health and maybe helping with energy and so on. But also there are risks. It's a dual purpose technology, harmful actors, bad actors could use it for harmful ends. And eventually, as AI, AI, technology becomes more autonomous, more agenteic and we get towards AGI, there's technological risk too. And so I worry a lot about all of those things. And I also, of course, we have to make sure that the engine and the economic engine works as well. So we have enough money to fund our research and fund things like alpha fold and give it to the world for free. That's not easy. It costs a lot of money to create something like in higher the research to create something like alpha fold. But we do a lot of things like that. And I want to do more things like that for the world. But that requires us to be successful also on the commercial side. So I think there's a balance to be had there. But the responsibility, I think, part comes as well is, and I feel like we can do this at Google as well, is we have the platform to show how AI can be deployed in a responsible way. And a beneficial way for all of society. And all of us who are fund tier labs producing AI, we have choices about what should we use AI for? We're going to use it for things like medicine and for alleviating administration and helping with things like poverty. Or we're going to use it for exploitative things. And I think that we're going to try and be a role model for all the good things that can come with AI. It doesn't mean we won't make any mistakes. We will do because it's such a nascent and complex technology. We'll try and be as thoughtful as possible as we can with it. And we'll try and be as scientific about it as possible, too. The scientific rigor we bring to our work and always have, I think, is going to matter here a lot. I mean, it's a scientific endeavor in the end. And then, I hope that what we, the kind of reliability and security and safety that we like to work on will come through in our products. And then I think the market will reward that because if you think about enterprises that use these technologies as they get more sophisticated, they're going to want to know, if you're a big bank or an insurance company, whatever health company that a medical company that you have some guarantees about what your AI systems that you're bringing in are going to do. And so I think that could be a good aspect of AI becoming very commercial is that there'll be commercial incentives to be robust and reliable and secure and all the things that you'd want actually in preparation for HGI coming into the world. So when you look at the year ahead, what do you think the story of AI will be? What will we achieve? Well, I think this year, I mean, every, I say this every year, that every year is pretty pivotal in AI. And it feels like it is the lows of us inside, it's working at the, at the coal phase, you know, like 10 years almost happens every year. And I think this year will be no different. It's very intense, but you've also got kind of every now and again, look up at the strategic picture. I think that, at least for us with Gemini 3, we crossed the watershed moment in my opinion. And hopefully those of you who have used it will feel that in that it's very capable now. And I'm certainly using it in my everyday life to help me with my research and summarising things and doing some coding. So I think that the systems are now ready to maybe build agents. We've talked, the whole industry has talked a lot about agents and more autonomous systems and delegating, hold tasks to them. But I think maybe by the end of this year where we really start seeing that, I'm very excited about assistance coming into the, real world with you, maybe on glasses. We have a big project on smart glasses. I think that the AI technology is only just about there to make that actually viable. And I think that could be a kind of killer app for four glasses. You know, I think that part bringing that into the world also robotics, I think is going to, I still think there's more research to be done in robotics, but I think over the next 18 months, or so I think we're going to see kind of breakthrough moment in robotics too. So all of these areas we're pushing very hard on as well as of course improving Gemini itself. Those are the glasses, right? No, they're not. These are just a little work for them. I would buy those if they weren't. They were like, yeah, I was going to ask you about the future form of how computers were not built for AI and all the things that AI can do. What do you think is the future first? Sounds like glasses. And you think we'll do that this year? I think last year would just be one of the solution. I have this side notion of, we talk about this notion internally of a universal assistant. And what we mean by that is an assistant that's super helpful in everyday life, recommending new things and reaching your life and dealing with admin, all of these types of things. But it goes across all the surfaces. So it's this on your computer, on your browser, on your phone. And then I think there'll be new devices too, like glasses. And it will be the same assistant that kind of understands your context across the different conversations you've had, whether that's in your car or in your office. And if you want it to, that can all be integrated together and I think help you improve your life across all those different aspects of your life. Maybe for Christmas next year, the holidays next year, we can all get our Google glasses. That's the idea. You ever just way too early, I think, before, when they can look a lot like that? I think you know, I've had a lot of things we've done at Google. We maybe were, you know, we pioneered all these spaces, perhaps a little bit too early in hindsight with glasses, both the technology of making them not too chunky and things. But also, I think it was missing the killer app. And I think an AI digital assistant could be that. Yeah, amazing. Well, one last question for you. I want to ask your biggest, boldest prediction for how AI will transform the world. When you look ahead, I know you said 10 years this one year now. It's true. But when you're looking ahead, are you like the abundance world where AI can solve all of our problems? Like, what does it look like? I think done right, we will be in an incredibly, you know, in 10, 15 years time, we'll be in a kind of new golden era of discovery. That's why hope, I kind of knew Renaissance. And I think human health will be revolutionized. It won't, medicine won't look like it does today. I think that personalized medicine, for example, will be a reality. And I think we'll have solved, used these AI technologies to solve many big problems in science and things like new materials, maybe help with fusion or solar or optimal batteries, some way of solving the energy crisis. And then I think we'll be in a world of radical abundance where we can use those energy sources to, you know, travel the stars and explore, you know, the galaxy. That's what I think our destiny is going to be. Amazing. Well, thank you. I hope that that's what you build. And thank you for all your efforts on it. Great to talk to you. Likewise.

Podcast Summary

Key Points:

  1. Demis Hassabis sold DeepMind to Google in 2014, a move he believed would be transformative and that spurred competitors like OpenAI.
  2. DeepMind’s AlphaGo victory in 2016 was a watershed moment that ignited the modern AI era.
  3. AlphaFold solved a 50-year-old protein folding problem, leading to a Nobel Prize and a free database used by millions of researchers.
  4. Hassabis leads Google’s AI efforts (including Gemini) and runs Isomorphic Labs, aiming to revolutionize drug discovery using AI.
  5. He combines interdisciplinary teams and manages time with a unique schedule, including late-night creative work.
  6. Merging DeepMind and Google Brain in 2023 revived a fast-shipping culture and refocused Google on AI innovation.

Summary:

In this interview, Demis Hassabis reflects on his journey from chess prodigy and astronomy enthusiast to leading Google’s AI revolution. He sold DeepMind to Google in 2014, foreseeing its pivotal role despite higher offers from Meta. This acquisition spurred the creation of OpenAI.

Hassabis highlights DeepMind’s key breakthroughs: AlphaGo’s 2016 victory, which launched the modern AI race, and AlphaFold, which solved a 50-year-old biology challenge by predicting protein structures. This work earned him a Nobel Prize and powers Isomorphic Labs, a startup aiming to “solve all disease” by using AI to accelerate drug discovery—reducing a decade-long, billion-dollar process to in silico design. At Google, Hassabis merged DeepMind and Google Brain to create Gemini, fostering a fast-shipping culture reminiscent of Google’s golden era.

He manages this dual role by leading interdisciplinary teams and working late nights for creative thinking. With founders like Sergey Brin now involved, Hassabis remains focused on ambitious goals: achieving artificial general intelligence and transforming human health through AI-driven science.

FAQs

January 2014 was when Demis Hassabis sold his AI company DeepMind to Google, a move that led to the creation of OpenAI by Elon Musk and Sam Altman.

Hassabis has a degree in computer science and a PhD in cognitive neuroscience, with interests in chess and astronomy. These interests led him to think about thinking and the brain, ultimately guiding him to AI and computers.

He was motivated by the mission to solve intelligence and scientific problems, believing that teaming up with Google would accelerate progress due to their enormous compute power.

AlphaFold is an AI model that solved the 50-year-old challenge of predicting a protein's 3D structure from its amino acid sequence. It is crucial for understanding diseases and drug discovery, and over 3 million researchers use it daily.

Isomorphic aims to solve all disease with AI by building a general drug discovery engine that designs drugs in silico, making the process far more efficient than traditional methods.

He packs his day with back-to-back meetings, spends time with family in the evening, and then works from 10 PM to 4 AM on creative and research work. He relies on strong interdisciplinary teams to manage both companies.

Chat with AI

Loading...

Pro features

Go deeper with this episode

Unlock creator-grade tools that turn any transcript into show notes and subtitle files.